2015 Nurse's Drug Handbook Jones & Bartlett [PDF][StormRG] torrent

TITLE/EDITION 2015 Nurse's Drug Handbook
By: Jones & Bartlett Learning
Series: Nurse's Drug Handbook
Paperback: 1430 pages
Publisher: Jones & Bartlett Learning; 14 edition (November 24, 2014)
Language: English
ISBN-10: 1284054616
ISBN-13: 978-1284054613
NOTE: This is the standalone ebook and may not include access codes that come packaged with the bound book

___________________________________________________________________________________


Jones & Bartlett Learning 2015 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from abatacept to zonisamide. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically. Jones & Bartlett Learning 2015 Nurse’s Drug Handbook includes: * Index of all generic, trade, and alternate drug names * Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule * Indications and dosages, as well as route, onset, peak, and duration information * Incompatibilities and contraindications * Interactions with drugs, food, and activities * Adverse reactions * Nursing considerations, including key teaching points for patients * Mechanism-of-action illustrations * Warnings and precautions New drug entries: hydrocodone bitartrate, levomilnacipran hydrochloride, lomitapide mesylate, mipomersen sodium, prothrombin complex concentrate (human), and vortioxetine hydrobromide. New to the Appendices: * Selected Ophthalmic Drugs: brinzolamide/brimonidine tartrate * Antihistamines: carbinoxamine maleate * Selected Topical Drugs: adapalene/benzolyl peroxide, brimonidine, desoximetasone, luliconazole, and urea * Antivirals: dolutegravir, simeprevir, and sofosbuvir * Antineoplastic Drugs: erlotinib, ibrutinib, lenalidomide, obinutuzumab, ofatumumab, romidepsin, trametinib, vandetanib, and vemurafenib